According to Advanced Accelerator Applications, the Novartis company executed a sales and purchase agreement for land on which a 50,000 square foot targeted Radioligand Therapy manufacturing plant will be built within Purdue Research Park.
Starting in 2023, AAA will produce Lutathera, a radiotherapy to treat neuroendocrine tumors and other radiotherapy treatments at its second U.S. manufacturing complex.
“The facility is intended to support near and long-term manufacturing capacity planning for AAA’s marketed products and for clinical supply. Initially, several production lines will be installed, with plans to further expand capacity. The facility will be built to the highest quality standards of safe and efficient operations," AAA officials said.
Mike Rossi, General Manager, US for Advanced Accelerator Applications said, “We are excited by the response to our first targeted Radioligand Therapy, LUTATHERA (lutetium Lu 177 dotatate), in the US market and expect to follow this success with new treatments for other cancer types. Given the growing demand for these targeted treatments and the need to deliver such drugs to patients within a few days of production, we are expanding our US manufacturing footprint with this new site.”
Indiana Secretary of Commerce, Jim Schellinger said, “Indiana’s pro-growth business climate and 21st century talent pipeline makes us an ideal destination for companies like Advanced Accelerator Applications, and we are so thrilled to be home to their new manufacturing facility. We look forward to supporting them and watching them continue to thrive, creating high-quality career opportunities for Hoosiers in the process.”
Mayor Joe Hogsett commented, “Indianapolis is proud to have been selected as the location for this new production facility. Today’s announcement continues our focus on the growth of Opportunity Industries 2 that, beyond the research and innovation they represent, provide sustainable career opportunities for area residents. This decision by Advanced Accelerator Applications further affirms the reputation of the Purdue Research Park network as a premiere center for technology-based companies, and I look forward to their success in Indy.”